Medical News Today

Nurtec ODT and pregnancy, breastfeeding, and birth control

If you can become pregnant, it’s important to consider whether Nurtec ODT is a safe choice for you. It’s unknown whether Nurtec ODT is safe to take during pregnancy. There aren’t any human studies of ...
Business Insider

Biohaven Announces Patient Savings Program Where Patients Can Pay as Little as $0 for NURTEC™ ODT (rimegepant 75 mg) for the Acute Treatment of Migraine in Adults

NEW HAVEN, Conn., March 13, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced a Patient Savings Program for NURTEC™ ODT (rimegepant) that is now available ...
Nasdaq

NURTEC® ODT Approved In Kuwait For Acute Treatment Of Migraine

- Registration approval of NURTEC ODT in Kuwait is third in Middle East region, joining prior market approvals in Israel and United Arab Emirates - NURTEC ODT is the first and only calcitonin ...
Drug Store News

FDA clears preventive indication for Nurtec ODT

Biohavan’s Nurtec ODT has a new indication. The drug has received the Food and Drug Administration’s approval for the preventive treatment of migraine. The product, first approved in February 2020 to ...
Business Insider

Biohaven's NURTEC™ ODT (rimegepant 75mg) is Now Available in U.S. Pharmacies for the Acute Treatment of Migraine in Adults

NEW HAVEN, Conn., March 12, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company (NYSE: BHVN) today announced that NURTEC™ ODT (rimegepant) is now available by prescription in U.S. pharmacies.
CNN

Biohaven's NURTEC™ ODT (rimegepant) Receives FDA Approval for the Acute Treatment of Migraine in Adults

NEW HAVEN, Conn., Feb. 27, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that the U.S. Food and Drug Administration (FDA) has approved NURTEC™ ODT ...
Monthly Prescribing Reference

Nurtec ODT Approval Expanded to Include Migraine Prevention

Rimegepant is an oral calcitonin gene-related peptide receptor antagonist. The Food and Drug Administration (FDA) has expanded the approval of Nurtec ® ODT (rimegepant) to include preventive treatment ...
CNN

Biohaven Enters Into Agreement With Genpharm for Distribution of NURTEC™ ODT in the Middle East

NEW HAVEN, Conn., April 27, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven") and Genpharm Services, a leading partner for innovative pharmaceuticals in Dubai ...
Main Line

Biohaven’s Nurtec ODT Garners Greater Early-Line Use as a Preventive Therapy Among Patients with Less Severe Migraine Compared to Eli Lilly’s Emgality, According to Spherix ...

EXTON, Pa., Sept. 23, 2021 /PRNewswire/ — Just weeks after the FDA approval of Nurtec ODT’s label expansion for the preventive treatment of episodic migraine, Eli Lilly announced initiation of a ...
KING5

Nurtec ODT: Quick-dissolving tablets relieve migraine headaches

SEATTLE — Approximately 15% of the U.S. population - 40 million Americans - suffer from Migraine, a disabling disease characterized by attacks with pulsating headaches that can last anywhere from 4 to ...
Nasdaq

Biohaven's NURTEC™ ODT (rimegepant 75mg) is Now Available in U.S. Pharmacies for the Acute Treatment of Migraine in Adults

NEW HAVEN, Conn., March 12, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company (NYSE: BHVN) today announced that NURTEC™ ODT (rimegepant) is now available by prescription in U.S. pharmacies.